Program Overview:
Meet with the newest institute at the NIH called the National Center for Advancing Translational Sciences (NCATS). By design, NCATS was formed to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster.

NCATS directly addresses the obstacles scientists face when developing a novel drug, device or other intervention. They are committed to uncovering new technologies and other approaches that could greatly accelerate the development and deployment of solutions that all translational researchers can use.

The NCATS approach is distinct in many ways and has already made a significant impact. Successes include 19 INDs that have been cleared by the FDA, twelve projects have been evaluated in clinical trials, and three agents have gone as far as Phase II human clinical trials. Additionally, third-party investors have licensed seven agents that have been developed through NCATS programs.

Join us to learn more about NCATS and their innovative approach. Following an overview of NCATS\’ opportunities and key areas of interest, don\’t miss the opportunity to introduce yourself during the networking lunch. Finally, for those companies who applied online and were approved, one-on-one meetings with NCATS will provide a forum to further discuss your company.

NCATS is seeking to collaborate with companies focusing on translating bench top discoveries to clinical hypothesis testing.

Agenda:
10:00 AM | Registration & Networking
10:30 AM | Presentation & Q&A
12:00 PM | Lunch & Networking
1:00 PM | One-on-one Meetings*
4:30 PM | Program Close

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on August 10th.